Annovis Bio (FRA:07X) General and Admin. Expense: €3.87 Mil (TTM As of Mar. 2026)

Annovis Bio FRA:07X +3.50% 32 General and Admin. Expense is €3.87 Mil as of Mar. 2026. GuruFocus rates FRA:07X with a GF Score™ of 32/100. The stock has 1 warning sign investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Annovis Bio's General and Admin. Expense for the three months ended in Mar. 2026 was €1.12 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 was €3.87 Mil.

Annovis Bio General and Admin. Expense Related Terms

Annovis Bio General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Annovis Bio's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Annovis Bio General and Admin. Expense Chart

Annovis Bio Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

General and Admin. Expense

Get a 7-Day Free Trial

5.36

8.49

5.73

6.40

3.83

Annovis Bio Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
General and Admin. Expense	Get a 7-Day Free Trial															1.18	0.96	0.98	0.82	1.12

32GF Score

Annovis Bio Inc FRA:07X

General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Annovis Bio General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.87 Mil.

Frequently Asked Questions Learn more about General and Admin. Expense →

What does a General and Admin. Expense of €3.87 Mil mean?

Annovis Bio (FRA:07X) has a General and Admin. Expense of €3.87 Mil as of Mar. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Annovis Bio and its competitors.

Is Annovis Bio's General and Admin. Expense too high?

Annovis Bio's current General and Admin. Expense is €3.87 Mil. Overall, Annovis Bio has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.

How does Annovis Bio's General and Admin. Expense compare to HYFT and EXOZ?

Annovis Bio's General and Admin. Expense of €3.87 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good General and Admin. Expense for a Biotechnology company?

A good General and Admin. Expense depends on the Biotechnology industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high General and Admin. Expense mean?

A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Annovis Bio and its competitors. Annovis Bio's current General and Admin. Expense is €3.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Annovis Bio stock overvalued right now?

Annovis Bio (FRA:07X) has a current General and Admin. Expense of €3.87 Mil. The current General and Admin. Expense is €3.87 Mil. Annovis Bio's overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is General and Admin. Expense calculated?

General and Admin. Expense is calculated from a company's financial statements. For Annovis Bio (FRA:07X), the current General and Admin. Expense is €3.87 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Annovis Bio Business Description

Industry Healthcare Biotechnology

Comparable Companies HYFT EXOZ ACRV GANX XBIT ELTX GOSS BYSI PLRX MCRB VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges ANVS:USA

Address 101 Lindenwood Drive, Suite 225, Malvern, PA, USA, 19355

Website https://www.annovisbio.com

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.

32GF Score

Get the complete analysis for FRA:07X

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.65

Price

View FRA:07X Analysis

See General and Admin. Expense data for all stocks →